• Molecular NameFencamfamine
  • Synonym2-Aethylamino-3-phenyl-nor-camphan; 2-Ethylamino-3-phenyl-norcamphane hydrochloride; 2-Ethylamino-3-phenylnorcamphane hydrochloride; Fencamfamin; Fencamfamin hydrochloride; Fencamfamina [dcit]; Fencamfamine [inn-french]; Fencamfamine hydrochloride; Fencamfaminum [inn-latin]; Fencanfamina [inn-spanish]
  • Weight215.34
  • Drugbank_IDDB01463
  • ACS_NO2240-14-4
  • Show 3D model
  • LogP (experiment)3.2
  • LogP (predicted, AB/LogP v2.0)3.08
  • pka8.7
  • LogD (pH=7, predicted)0.19
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.19
  • LogSw (predicted, AB/LogsW2.0)0.28
  • Sw (mg/ml) (predicted, ACD/Labs)0.29
  • No.of HBond Donors1
  • No.of HBond Acceptors1
  • No.of Rotatable Bonds3
  • TPSA12.03
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA stimulant which was developed in the 1960s as an appetite suppressant
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeDerived from urinary excretion data, about 16 h.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A